Derma Sciences (NASDAQ:DSCI) & Cogentix Medical (CGNT) Critical Contrast

Cogentix Medical (NASDAQ: CGNT) and Derma Sciences (NASDAQ:DSCI) are both advanced medical equipment & technology – nec companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Insider & Institutional Ownership

12.5% of Cogentix Medical shares are owned by institutional investors. Comparatively, 58.9% of Derma Sciences shares are owned by institutional investors. 62.7% of Cogentix Medical shares are owned by company insiders. Comparatively, 9.9% of Derma Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Cogentix Medical and Derma Sciences, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cogentix Medical 0 0 2 0 3.00
Derma Sciences 0 1 0 0 2.00

Cogentix Medical currently has a consensus target price of $4.50, indicating a potential upside of 61.29%. Given Cogentix Medical’s stronger consensus rating and higher probable upside, research analysts plainly believe Cogentix Medical is more favorable than Derma Sciences.

Profitability

This table compares Cogentix Medical and Derma Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cogentix Medical -36.14% -11.52% -10.04%
Derma Sciences -20.97% -17.10% -12.43%

Earnings and Valuation

This table compares Cogentix Medical and Derma Sciences’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Cogentix Medical $51.85 million 3.28 -$22.09 million ($0.41) -6.80
Derma Sciences N/A N/A N/A ($0.31) -22.58

Derma Sciences has higher revenue, but lower earnings than Cogentix Medical. Derma Sciences is trading at a lower price-to-earnings ratio than Cogentix Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Cogentix Medical beats Derma Sciences on 7 of the 10 factors compared between the two stocks.

About Cogentix Medical

Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

About Derma Sciences

Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company’s advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company’s traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply